Important prognostic value of standardized objective criteria of response in stage D2 prostatic carcinoma

This publication has 16 references indexed in Scilit:

• Development of androgen resistance in mouse mammary tumor cells can be prevented by the antiandrogen flutamide
  The Prostate, 1987
• Comparison of Diethylstilbestrol, Cyproterone Acetate and Medroxyprogesterone Acetate in the Treatment of Advanced Prostatic Cancer: Final Analysis of a Randomized Phase III Trial of the European Organization for Research on Treatment of Cancer Urological Group
  Journal of Urology, 1986
• Characteristics of interaction of the antiandrogen flutamide with the androgen receptor in various target tissues
  Molecular and Cellular Endocrinology, 1986
• A wide range of sensitivities to androgens develops in cloned shionogi mouse mammary tumor cells
  The Prostate, 1986
• Treatment of newly diagnosed metastatic prostate cancer patients with chemotherapy agents in combination with hormones versus hormones alone
  Cancer, 1983
• The Value of Nuclear Bone Imaging in Advanced Prostatic Cancer
  Journal of Urology, 1981
• Chemotherapy of advanced prostatic cancer Evaluation of response parameters
  Urology, 1976
• The influence of site of metastasis on tumour growth and response to chemotherapy
  British Journal of Cancer, 1975
• The natural history of prostatic cancer
  Cancer, 1973
• Nonparametric Estimation from Incomplete Observations
  Journal of the American Statistical Association, 1958